Vanguard Group’s Ocular Therapeutix OCUL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $77.9M | Buy |
8,392,175
+27,660
| +0.3% | +$257K | ﹤0.01% | 1933 |
|
2025
Q1 | $61.3M | Sell |
8,364,515
-119,398
| -1% | -$875K | ﹤0.01% | 2008 |
|
2024
Q4 | $72.5M | Buy |
8,483,913
+99,730
| +1% | +$852K | ﹤0.01% | 2004 |
|
2024
Q3 | $72.9M | Sell |
8,384,183
-227,918
| -3% | -$1.98M | ﹤0.01% | 2025 |
|
2024
Q2 | $58.9M | Buy |
8,612,101
+1,376,970
| +19% | +$9.42M | ﹤0.01% | 2082 |
|
2024
Q1 | $65.8M | Buy |
7,235,131
+2,117,029
| +41% | +$19.3M | ﹤0.01% | 2052 |
|
2023
Q4 | $22.8M | Buy |
5,118,102
+1,057,123
| +26% | +$4.71M | ﹤0.01% | 2535 |
|
2023
Q3 | $12.8M | Buy |
4,060,979
+8,152
| +0.2% | +$25.6K | ﹤0.01% | 2741 |
|
2023
Q2 | $20.9M | Buy |
4,052,827
+11,437
| +0.3% | +$59K | ﹤0.01% | 2572 |
|
2023
Q1 | $21.3M | Buy |
4,041,390
+64,537
| +2% | +$340K | ﹤0.01% | 2561 |
|
2022
Q4 | $11.2M | Buy |
3,976,853
+25,047
| +0.6% | +$70.4K | ﹤0.01% | 2903 |
|
2022
Q3 | $16.4M | Buy |
3,951,806
+53,255
| +1% | +$221K | ﹤0.01% | 2717 |
|
2022
Q2 | $15.7M | Sell |
3,898,551
-296,855
| -7% | -$1.19M | ﹤0.01% | 2766 |
|
2022
Q1 | $20.8M | Buy |
4,195,406
+116,383
| +3% | +$576K | ﹤0.01% | 2752 |
|
2021
Q4 | $28.4M | Buy |
4,079,023
+394,174
| +11% | +$2.75M | ﹤0.01% | 2655 |
|
2021
Q3 | $36.8M | Buy |
3,684,849
+15,884
| +0.4% | +$159K | ﹤0.01% | 2527 |
|
2021
Q2 | $52M | Buy |
3,668,965
+25,902
| +0.7% | +$367K | ﹤0.01% | 2354 |
|
2021
Q1 | $59.8M | Buy |
3,643,063
+93,065
| +3% | +$1.53M | ﹤0.01% | 2218 |
|
2020
Q4 | $73.5M | Buy |
3,549,998
+571,235
| +19% | +$11.8M | ﹤0.01% | 1997 |
|
2020
Q3 | $22.7M | Sell |
2,978,763
-28,396
| -0.9% | -$216K | ﹤0.01% | 2397 |
|
2020
Q2 | $25.1M | Buy |
3,007,159
+907,320
| +43% | +$7.56M | ﹤0.01% | 2309 |
|
2020
Q1 | $10.4M | Buy |
2,099,839
+91,032
| +5% | +$451K | ﹤0.01% | 2605 |
|
2019
Q4 | $7.93M | Sell |
2,008,807
-2,189
| -0.1% | -$8.65K | ﹤0.01% | 2966 |
|
2019
Q3 | $6.11M | Buy |
2,010,996
+139,049
| +7% | +$423K | ﹤0.01% | 3060 |
|
2019
Q2 | $8.24M | Buy |
1,871,947
+234,360
| +14% | +$1.03M | ﹤0.01% | 2971 |
|
2019
Q1 | $6.5M | Buy |
1,637,587
+50,534
| +3% | +$201K | ﹤0.01% | 3037 |
|
2018
Q4 | $6.32M | Buy |
1,587,053
+159,520
| +11% | +$635K | ﹤0.01% | 2985 |
|
2018
Q3 | $9.82M | Buy |
1,427,533
+92,335
| +7% | +$635K | ﹤0.01% | 2930 |
|
2018
Q2 | $9.01M | Sell |
1,335,198
-9,343
| -0.7% | -$63.1K | ﹤0.01% | 2956 |
|
2018
Q1 | $8.75M | Buy |
1,344,541
+273,677
| +26% | +$1.78M | ﹤0.01% | 2882 |
|
2017
Q4 | $4.77M | Buy |
1,070,864
+41,960
| +4% | +$187K | ﹤0.01% | 3154 |
|
2017
Q3 | $6.36M | Buy |
1,028,904
+123,448
| +14% | +$763K | ﹤0.01% | 3017 |
|
2017
Q2 | $8.39M | Buy |
905,456
+3,194
| +0.4% | +$29.6K | ﹤0.01% | 2859 |
|
2017
Q1 | $8.37M | Buy |
902,262
+174,688
| +24% | +$1.62M | ﹤0.01% | 2840 |
|
2016
Q4 | $6.09M | Sell |
727,574
-22,300
| -3% | -$187K | ﹤0.01% | 2973 |
|
2016
Q3 | $5.15M | Buy |
749,874
+270,565
| +56% | +$1.86M | ﹤0.01% | 2989 |
|
2016
Q2 | $2.37M | Buy |
479,309
+23,793
| +5% | +$118K | ﹤0.01% | 3322 |
|
2016
Q1 | $4.4M | Buy |
455,516
+3,938
| +0.9% | +$38K | ﹤0.01% | 3032 |
|
2015
Q4 | $4.23M | Buy |
451,578
+22,163
| +5% | +$208K | ﹤0.01% | 3064 |
|
2015
Q3 | $6.04M | Buy |
429,415
+118,883
| +38% | +$1.67M | ﹤0.01% | 2881 |
|
2015
Q2 | $6.53M | Buy |
310,532
+137,530
| +79% | +$2.89M | ﹤0.01% | 2880 |
|
2015
Q1 | $7.26M | Buy |
173,002
+98,663
| +133% | +$4.14M | ﹤0.01% | 2804 |
|
2014
Q4 | $1.75M | Buy |
74,339
+35,017
| +89% | +$824K | ﹤0.01% | 3333 |
|
2014
Q3 | $588K | Buy |
+39,322
| New | +$588K | ﹤0.01% | 3674 |
|